NYT Form 4: Director adds 59 dividend-equivalent shares, holds 19,720
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
The New York Times Company (NYT) filed a Form 4 reporting insider activity. Director Beth A. Brooke acquired 59 shares of Class A Common Stock at $0 on October 23, 2025. The shares reflect dividend-equivalent restricted stock units credited under the company’s 2020 Incentive Compensation Plan when cash dividends were paid.
Following this transaction, Brooke beneficially owns 19,720 shares directly. Dividend-equivalent RSUs tied to vested RSUs are fully vested at grant; those tied to unvested RSUs vest on the same date the underlying RSUs vest, which is the date of the company’s first annual meeting following the initial grant.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Brooke Beth A.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Class A Common Stock | 59 | $0.00 | -- |
Holdings After Transaction:
Class A Common Stock — 19,720 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What did New York Times (NYT) disclose in this Form 4?
A director, Beth A. Brooke, acquired 59 Class A shares on October 23, 2025 at $0 via dividend-equivalent RSUs.
How do dividend-equivalent RSUs vest at NYT?
Those linked to vested RSUs are fully vested at grant; those linked to unvested RSUs vest on the same date the underlying RSUs vest, at the first annual meeting following the initial grant.
What role does the reporting person hold at NYT?
Beth A. Brooke is a Director of The New York Times Company.